With over 20 years of leadership experience in corporate management and international market development, Mr. Jack Wang has served as a core executive at multiple industry-leading companies. His extensive background spans global pharmaceutical development, international trade, overseas investments, and global footprint expansion.

At CanSinoBIO, Mr. Wang leads the overarching globalization strategy. He drives critical initiatives across overseas market access, international technology transfer, strategic investment, global capacity planning, and international clinical data harmonization.

He has been instrumental in driving CanSinoBIO's strategic upgrade from mere "product export" to a holistic global expansion of "technology + standards + brand." The innovative internationalization model he has pioneered provides a replicable and scalable paradigm for Chinese biopharma companies aiming to deeply integrate into global public health governance.